Dsam Partners (london) Ltd adds Rite Aid Corporation (RAD) to its portfolio

Rite Aid Corporation (RAD) : Dsam Partners (london) Ltd added new position in Rite Aid Corporation during the most recent quarter end. The investment management firm now holds 1,876,566 shares of Rite Aid Corporation which is valued at $14.9 Million , the company said in a statement filed on May 13, 2016 with the SEC.Rite Aid Corporation makes up approximately 7.51% of Dsam Partners (london) Ltd’s portfolio.

Other Hedge Funds, Including , Citadel Advisors boosted its stake in RAD in the latest quarter, The investment management firm added 420,552 additional shares and now holds a total of 571,310 shares of Rite Aid Corporation which is valued at $4.5 Million. Rite Aid Corporation makes up approx 0.01% of Citadel Advisors’s portfolio.Edmond De Rothschild Holding S.a. reduced its stake in RAD by selling 230,000 shares or 27.71% in the most recent quarter. The Hedge Fund company now holds 600,000 shares of RAD which is valued at $4.8 Million. Rite Aid Corporation makes up approx 0.16% of Edmond De Rothschild Holding S.a.’s portfolio.Cqs Cayman Lp boosted its stake in RAD in the latest quarter, The investment management firm added 107,500 additional shares and now holds a total of 427,500 shares of Rite Aid Corporation which is valued at $3.4 Million. Rite Aid Corporation makes up approx 0.84% of Cqs Cayman Lp’s portfolio.Tci Wealth Advisors boosted its stake in RAD in the latest quarter, The investment management firm added 3,774 additional shares and now holds a total of 5,774 shares of Rite Aid Corporation which is valued at $46,481. Rite Aid Corporation makes up approx 0.03% of Tci Wealth Advisors’s portfolio.

Rite Aid Corporation opened for trading at $7.65 and hit $7.72 on the upside on Wednesday, eventually ending the session at $7.66, with a gain of 0.39% or 0.03 points. The heightened volatility saw the trading volume jump to 1,60,35,588 shares. Company has a market cap of $8,031 M.

On the company’s financial health, Rite Aid Corporation reported $0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Apr 7, 2016. Analyst had a consensus of $0.06. The company had revenue of $8270.00 million for the quarter, compared to analysts expectations of $8398.20 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.12 EPS.

Many Wall Street Analysts have commented on Rite Aid Corporation. Deutsche Bank Downgraded Rite Aid Corporation on Apr 8, 2016 to ” Hold”, Price Target of the shares are set at $9.Rite Aid Corporation was Resumed by Credit Suisse to “Outperform” on Mar 16, 2016.

Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise which are referred to as front-end products. The Company’s drugstores’ primary business is pharmacy services. It operates approximately 4570 stores in 31 states across the country and in the District of Columbia. Its front-end products include over-the-counter medications health and beauty aids personal care items cosmetics household items food and beverages greeting cards seasonal merchandise and various other every day and convenience products. The Company offers a range of products through its portfolio of private brands. Its classes of products include prescription drugs over-the-counter medications and personal care health and beauty aids and general merchandise and other. It sells private brand and co-branded products. It operates under The Rite Aid name.

Leave a Reply

Rite Aid Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Rite Aid Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.